U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07180277) titled 'Methylprednisolone for Moderate to Severe Traumatic Brain Injury' on Sept. 09.
Brief Summary: The goal of this clinical trial is to learn if standard-dose methylprednisolone sodium succinate can improve neurological recovery and safety in adults with moderate to severe traumatic brain injury (TBI). The main questions it aims to answer are:
1. Does adding a 5-day course of methylprednisolone improve overall long-term neurological outcome compared with placebo?
2. Does methylprednisolone reduce 6-month mortality or increase the proportion of patients with good neurological recovery?
3. What medical problems do participants experie...